Accelerated radiotherapy with concomitant boost technique (69.5 Gy/5 weeks)
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F11%3A00102034" target="_blank" >RIV/00843989:_____/11:00102034 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00064211:_____/11:#0000220
Výsledek na webu
<a href="http://dx.doi.org/10.1007/s00066-011-2246-2" target="_blank" >http://dx.doi.org/10.1007/s00066-011-2246-2</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00066-011-2246-2" target="_blank" >10.1007/s00066-011-2246-2</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Accelerated radiotherapy with concomitant boost technique (69.5 Gy/5 weeks)
Popis výsledku v původním jazyce
Background and Purpose: To present the feasibility and results of accelerated radiotherapy with concomitant boost technique (69.5 Gy/5 weeks) in the treatment of locally advanced head and neck cancer. Patients and Methods: A total of 65 patients were treated between June 2006 and August 2009. The distribution of clinical stages was as follows: II 11%, III 23%, IV 61%, and not defined 5%. Results: The median follow-up was 30.5 months. The treatment plan was completed in 94% of patients. Patients were treated using the conformal or intensity-modulated radiotherapy (IMRT) technique. The median overall treatment time was 37 days (13-45 days). The mean radiotherapy dose was 68.4 Gy (16-74 Gy). Overall survival was 69% after 2 years. Disease-free survival was 62% after 2 years. Acute toxicity >= grade 3(RTOG scale) included mucositis (grade 3:42.6%), pharynx (grade 3:42.3%), skin (grade 3: 9.5%), larynx (grade 3: 4%), while late toxicity affected skin (grade 3:6.25%) and salivary glands (gra
Název v anglickém jazyce
Accelerated radiotherapy with concomitant boost technique (69.5 Gy/5 weeks)
Popis výsledku anglicky
Background and Purpose: To present the feasibility and results of accelerated radiotherapy with concomitant boost technique (69.5 Gy/5 weeks) in the treatment of locally advanced head and neck cancer. Patients and Methods: A total of 65 patients were treated between June 2006 and August 2009. The distribution of clinical stages was as follows: II 11%, III 23%, IV 61%, and not defined 5%. Results: The median follow-up was 30.5 months. The treatment plan was completed in 94% of patients. Patients were treated using the conformal or intensity-modulated radiotherapy (IMRT) technique. The median overall treatment time was 37 days (13-45 days). The mean radiotherapy dose was 68.4 Gy (16-74 Gy). Overall survival was 69% after 2 years. Disease-free survival was 62% after 2 years. Acute toxicity >= grade 3(RTOG scale) included mucositis (grade 3:42.6%), pharynx (grade 3:42.3%), skin (grade 3: 9.5%), larynx (grade 3: 4%), while late toxicity affected skin (grade 3:6.25%) and salivary glands (gra
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FD - Onkologie a hematologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2011
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Strahlentherapie und Onkologie
ISSN
0179-7158
e-ISSN
—
Svazek periodika
187
Číslo periodika v rámci svazku
10
Stát vydavatele periodika
DE - Spolková republika Německo
Počet stran výsledku
5
Strana od-do
651-655
Kód UT WoS článku
000295853800007
EID výsledku v databázi Scopus
—